CMS’ proposed changes to the Medicare Shared Savings Program (MSSP) doesn’t represent a major shift in policy stance toward accountable care organizations (ACOs), said Joe Antos, PhD, the Wilson H. Taylor Resident Scholar in Health Care and Retirement Policy at the American Enterprise Institute.
CMS’ proposed changes to the Medicare Shared Savings Program (MSSP) doesn’t represent a major shift in policy stance toward accountable care organizations (ACOs), said Joe Antos, PhD, the Wilson H. Taylor Resident Scholar in Health Care and Retirement Policy at the American Enterprise Institute.
Transcript
If the proposed CMS changes to the MSSP are expected to make fewer ACOs participate, do you think the proposal will affect the ACO movement?
I wouldn’t say that this is a major change in policy with regard to ACOs. The current administration has clearly accepted the concept of ACOs, they’re clearly trying to promote them in a way.
I would say that Andy Slavitt, who was the CMS administrator under [President] Obama, said something to the effect of “yeah, there should be a time limit and if you’re not successful within a reasonable time limit, then you should go. Because it’s not going to work out for you.” So, I think that’s kind of a hard-eyed business look at this. But I don’t think this is a major change in policy.
They’re going to have to do other things to either strongly promote ACOs or strongly discourage them. I think one of the things that would promote ACOs or promote movement toward a more sensible approach to delivery, in general, would be to follow some of MedPAC [Medicare Payment Advisory Commission]’s suggestions with regard to fixing MIPS [Merit-based Incentive Payment System] and fixing MACRA [Medicare Access and CHIP Reauthorization Act], which is a problem all by itself.
Key Indicators of Myasthenia Gravis Disease Progression Reduced With Efgartigimod
April 18th 2025Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients who have anti-acetylcholine receptor antibody-positive myasthenia gravis that include reduced exacerbations and need for immunoglobulin.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bias Reduction, Better Access Key to COVID-19 Equity Gains
April 14th 2025Interventions that target enhancing health care equity among communities disproportionately affected by the COVID-19 pandemic can be improved by including comprehensive needs assessments at the patient, provider, and health system levels.
Read More
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More